Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.59 |
| ▸ | HTR2C | P28335 | 1/20 | 0.59 |
| ▸ | HTR2B | P41595 | 1/20 | 0.59 |
| ▸ | KDM1A | O60341 | 17/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.48 |
| ▸ | KDM1B | Q8NB78 | 3/20 | 0.48 |
| ▸ | MAOB | P27338 | 5/20 | 0.48 |
| ▸ | MAOA | P21397 | 3/20 | 0.48 |
| ▸ | RCOR1 | Q9UKL0 | 2/20 | 0.48 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12971950 | 1.00 | HTR2A (0.59) | HTR2AHTR2CHTR2BKDM1AKCNH2 | |
| SCHEMBL6997479 | 1.00 | HTR2A (0.59) | HTR2AHTR2CHTR2BKDM1AKCNH2 | |
| SCHEMBL7001620 | 0.82 | CYP3A4 (0.45) | KDM1AKCNH2KDM1BMAOBMAOA | |
| SCHEMBL7092112 | 0.82 | KCNH2 (0.45) | KDM1AKCNH2KDM1BMAOBMAOA | |
| SCHEMBL7092720 | 0.82 | HTR2A (0.63) | HTR2AHTR2CHTR2BKDM1AKCNH2 | |
| SCHEMBL8134479 | 0.82 | CYP3A4 (0.45) | KDM1AKCNH2KDM1BMAOBMAOA | |
| SCHEMBL7092719 | 0.82 | HTR2A (0.63) | HTR2AHTR2CHTR2BKDM1AKCNH2 | |
| SCHEMBL7001619 | 0.82 | CYP3A4 (0.45) | KDM1AKCNH2KDM1BMAOBMAOA | |
| SCHEMBL7003893 | 0.82 | KCNH2 (0.45) | KDM1AKCNH2KDM1BMAOBMAOA | |
| SCHEMBL7865950 | 0.82 | HTR2A (0.63) | HTR2AHTR2CHTR2BKDM1AKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0996621-B1 | TRIAZOLO[4,5-d]PYRIMIDINE DERIVATIVES AS ANTI-THROMBOTIC AGENTS | ASTRAZENECA AB (SE) | 2003-10-01 | — | — | EP | disclosed |
| US-6251910-B1 | 1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists | ASTRAZENECA UK LIMITED (GB) | 2001-06-26 | — | — | US | disclosed |